NovoCure (NVCR) Inventory Average (2016 - 2025)
NovoCure (NVCR) has disclosed Inventory Average for 11 consecutive years, with $40.1 million as the latest value for Q4 2025.
- Quarterly Inventory Average rose 8.13% to $40.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40.1 million through Dec 2025, up 8.13% year-over-year, with the annual reading at $38.1 million for FY2025, 4.04% up from the prior year.
- Inventory Average hit $40.1 million in Q4 2025 for NovoCure, up from $39.7 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $41.4 million in Q2 2024 to a low of $23.5 million in Q4 2021.
- Historically, Inventory Average has averaged $33.3 million across 5 years, with a median of $33.6 million in 2023.
- Biggest five-year swings in Inventory Average: dropped 12.68% in 2021 and later surged 33.45% in 2023.
- Year by year, Inventory Average stood at $23.5 million in 2021, then rose by 19.33% to $28.1 million in 2022, then soared by 33.45% to $37.5 million in 2023, then dropped by 1.04% to $37.1 million in 2024, then grew by 8.13% to $40.1 million in 2025.
- Business Quant data shows Inventory Average for NVCR at $40.1 million in Q4 2025, $39.7 million in Q3 2025, and $39.8 million in Q2 2025.